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During the coronavirus disease 2019 (COVID-19) pandemic, we have witnessed profound health inequities suffered by Black, 
Indigenous, and People of Color (BIPOC). These manifested as differential access to testing early in the pandemic, rates of severe 
disease and death 2–3 times higher than white Americans, and, now, significantly lower vaccine uptake compared with their share 
of the population affected by COVID-19. This article explores the impact of these COVID-19 inequities (and the underlying cause, 
structural racism) on vaccine acceptance in BIPOC populations, ways to establish trustworthiness of healthcare institutions, increase 
vaccine access for BIPOC communities, and inspire confidence in COVID-19 vaccines.
Keywords.  Black, Indigenous, People of Color (BIPOC); COVID-19; structural racism; vaccine confidence.
The disproportionate coronavirus disease 2019 (COVID-
19) mortality among Black, Indigenous, and People of color 
(BIPOC) communities is driven by inequities created by struc-
tural racism, including higher poverty rates, lower wage (es-
sential worker) employment, and crowded living situations. 
Inequitable distribution of these social determinants of health 
influence risk factors for comorbidities, access to care, and de-
livery of care to different racial/ethnic groups [1–5]. Although 
the COVID-19 pandemic has amplified these racial and ethnic 
inequities, it has also highlighted the historical and current 
factors contributing to distrust of healthcare institutions by 
BIPOC communities. This legacy includes a history of invol-
untary medical treatment and experimentation, including the 
sustained ethical breach of 1932 US Public Health Service-
funded study of untreated syphilis in Black men at the Tuskegee 
Institute, in which penicillin was intentionally withheld from 
Black study participants without their knowledge for decades 
after it was known to be an effective therapy for syphilis [6]. It 
also includes a history of forced sterilization practices exerted 
on women in Indigenous communities without informed con-
sent at the hands of Indian Health Services (IHS) physicians 
[7]. Furthermore, American Indian/Alaska Native (AI/AN) 
communities are familiar with the devastating impacts of infec-
tious diseases on their communities, having experienced signif-
icant population reduction after introduction of diseases such 
as smallpox, measles, and influenza by European colonizers 
[8]. According to Desi Rodriguez-Lonebear, a social demogra-
pher at the University of Arizona and citizen of the Northern 
Cheyenne tribe in Montana, “More than any other population 
in the country, the shared experience of surviving a pandemic is 
in our blood, it’s not historic, it’s current for American Indians, 
it’s our reality. We took it seriously because we had to” [9].
A further long documented history of segregated and sub-
standard healthcare delivery has left a foundation of deep 
 
Received 4 June 2021; editorial decision 30 July 2021; accepted 6 August 2021.
Correspondence: Jasmine Riviere Marcelin, MD, FACP, FIDSA, Assistant Professor, Infectious 
Diseases, Associate Medical Director, Antimicrobial Stewardship Program, Co-Director, Digital 
Innovation & Social Media Strategy, Division of Infectious Diseases, University of Nebraska 
Medical Center, 985400 Nebraska Medical Center, Omaha, NE 68198-5400, USA (jasmine.
marcelin@unmc.edu) 
Open Forum Infectious Diseases®2021
© The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases 
Society of America. This is an Open Access article distributed under the terms of the Creative 
Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/
by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any 
medium, provided the original work is not altered or transformed in any way, and that the 







/ofid/article/8/9/ofab417/6346775 by Philadelphia C
ollege of O
steopathic M
edicine user on 11 O
ctober 2021
2 • ofid • Marcelin et al
wounds that persist today [10]. The propagation of beliefs re-
ifying race as a biological factor can have devastating outcomes 
for minoritized people [11]. Black, Hispanic, American Indian/
Alaska Native, and Native Hawaiian/Pacific Islander patients 
receive lower-quality care than white patients for 30%–40% 
of quality measures assessed by the Agency for Healthcare 
Research and Quality [12]. Although there have been steps 
taken to address historical wrongdoing, chronic underfunding 
and underresourcing of healthcare institutions primarily caring 
for minoritized communities limit the longevity of these gains. 
For example, the majority of AI/AN obtain care through a frag-
mented system dominated by the IHS, a chronically under-
funded federal agency that suffers from a widespread shortage 
of providers [13]. As a result, healthcare facilities serving this 
population may be at greater risk of being overwhelmed by the 
crisis than other US clinical facilities.
Furthermore, there is a dearth of healthcare professionals 
from BIPOC communities [14] and significant gaps in pay, ad-
vancement, and opportunity [15]. Most importantly, patient 
care is impacted by the lack of cultural diversity among health-
care professionals. For example, studies have demonstrated that 
Black patients experience poorer quality of communication and 
reduced shared decision-making compared with white patients, 
and racial concordance is clearly associated with better com-
munication [16]. Therefore, racially concordant public health 
messaging can have a significant impact in establishing trust in 
healthcare entities among BIPOC communities [17].
Consequently, the combination of historical events and con-
temporaneous inequities impacting BIPOC people attributed to 
structural racism has justifiably rendered healthcare institutions 
untrustworthy in the eyes of minoritized people. Herein lies the 
challenge faced during this pandemic where we now have vac-
cines proven effective at preventing severe disease and death: 
BIPOC communities are experiencing the worst morbidity and 
mortality of COVID-19 [18–25] yet Black and Hispanic popu-
lations are some of the least vaccinated groups in the United 
States [26–28].
An approach to increasing vaccine confidence and uptake 
in BIPOC communities must be creative, flexible, and nimble, 
addressing the heterogeneous concerns and barriers to vaccine 
access that people may have. In this study, we describe the nu-
ances of vaccine confidence in BIPOC communities, explore 
issues with vaccine access, and suggest that BIPOC healthcare 
professionals are well positioned to provide insight into pro-
moting vaccine uptake in minoritized populations.
CORONAVIRUS DISEASE 2019 AND BLACK, 
INDIGENOUS AND PEOPLE OF COLOR 
COMMUNITIES
The COVID-19 pandemic has resulted in more than 170 million 
infections and 3.5 million deaths worldwide [29]. The United 
States accounts for approximately one fifth of the global burden, 
with more than 33 million infections and almost 600 000 deaths 
as of June 1, 2021 [29]. The transmission and disease severity 
trends have highlighted key disparities in BIPOC communities, 
which have been overrepresented in COVID-19 infections, hos-
pitalizations, and deaths [30–32]. Social determinants of health 
underlie the disparate impact of COVID-19 on BIPOC com-
munities. These social determinants arise from long-standing 
systemic racism and health inequity, including disparities in 
healthcare access, employment and work conditions, trans-
portation, incarceration, and housing circumstances [30–32]. 
These factors increase the risk of transmission and dispropor-
tionately high rates of preexisting comorbid conditions that 
increase the risk of COVID-19 disease severity.
The high burden of COVID-19 disease and COVID-19-
related mortality in these populations makes the distribution 
and uptake of critical preventative tools such as COVID-19 
vaccines in BIPOC communities even more critical. Vaccine 
development efforts have included representation of BIPOC in-
dividuals in clinical trials, and there is guidance for equitable 
vaccine delivery and prioritizing populations at the highest 
risk [33]. However, there may be barriers to equitable vaccine 
uptake in BIPOC communities, including higher uninsurance 
rates and concerns about cost, less access to care, vaccine ap-
pointments conflicting with other commitments, transporta-
tion barriers, and others [34]. Accordingly, across the country, 
the proportion of BIPOC individuals being vaccinated lags be-
hind their share of the US population, and their share of the 
population affected by COVID-19 [28, 35], with the exception 
of AI/AN individuals, who have higher vaccination rates rela-
tive to other racial groups [36].
In addition, many individuals from BIPOC communities 
have expressed reluctance or barriers to receiving the available 
vaccines [37], with several national surveys reporting rates of 
reluctance ranging from 25% to 50% [38–41]. Among those ex-
pressing reluctance, reasons included safety concerns related to 
lack of sufficient time for vaccine development, a lack of trust 
in or having doubts about the government or the healthcare 
system, and high rates of concern that the development of the 
vaccine did not take their needs into account. These surveys re-
ported that for the BIPOC communities, confidence in vaccine 
safety and effectiveness were the number one predictor of vac-
cine intention. Thus, critical trust-building efforts must focus 
on healthcare institutions and professionals establishing their 
trustworthiness, by ensuring that communities have access to 
high-quality information that increases their understanding 
of the science behind vaccine development and mechanisms. 
These efforts must also consider the historical trauma and 
distrust of vaccinations, the government, and the healthcare 
system borne by BIPOC communities [40]. Reduced vaccine 
confidence within BIPOC communities must be appreciated 
within the extended historical context that has engendered con-
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historically informed mistrust of medical and public health sys-
tems remains coupled to known disparities in quality-of-care 
delivery experienced by BIPOC communities through today, 
undergirding skepticism of health systems and structures for 
even those with the highest health literacy in these communities.
VACCINE CONFIDENCE AMONG BIPOC 
HEALTHCARE PERSONNEL
Although white workers represent the majority of the overall 
healthcare workforce (64%), Black and Hispanic workers are 
more heavily concentrated in Healthcare Support and Personal 
Care and Services sectors [42]. The Centers for Disease Control 
and Prevention reported 412  091 cases of COVID-19 and 
1463 COVID-19 deaths among healthcare personnel (HCP) in 
the United States as of February 26, 2021 [42, 43]. Data from 
February to July 2020 showed that, among HCP COVID-19 
cases, healthcare support workers accounted for the largest pro-
portion within the HCP group (32%) [44]. For HCP who are 
members of historically disenfranchised racial/ethnic groups, 
decisions regarding the COVID vaccine are influenced by their 
professional backgrounds, historical context, and more recent 
experiences of differential treatment in the public sphere and 
the workplace [45, 46]. They may wrestle with whether to (1) 
advocate for vaccines as a major component of the strategy 
against a condition that has had a devastatingly dispropor-
tionate impact on their communities or to (2) maintain skep-
ticism, reservation, and protection of themselves and their 
communities against new vaccine tools in the face of mistrust 
engendered by this embedded historical experience [47, 48]. 
This issue is particularly challenging because some data suggest 
BIPOC healthcare providers may hold particularly heightened 
sway in influencing the decision of BIPOC community mem-
bers to obtain a COVID-19 vaccine [40, 41].
Efforts to promote equitable vaccine uptake for these HCP 
will therefore need to address these complexities. In a confiden-
tial survey conducted in 2 large hospitals at the end of 2020, 
concern about side-effects and not knowing enough about the 
vaccine were among the most common reasons (89.1% and 
77.9%, respectively) that employees indicated for not being 
willing to take a COVID-19 vaccine [49]. Only 29.7% of Black 
and 54.4% of Hispanic hospital employees in that study were 
planning to receive a COVID-19 vaccine, compared with 69.5% 
of white and 74.1% of Asian employees [49]. Information about 
COVID-19 vaccines provided to HCP should include accurate 
research findings and the details of the vaccine approval process 
to help answer questions about safety and efficacy for individ-
uals with a broad range of scientific knowledge, including HCP 
who work in nonclinical roles [45]. Healthcare personnel who 
are members of BIPOC communities may also witness and ex-
perience discriminatory practices in the settings in which they 
work that reinforce concerns that they may not be treated fairly, 
despite working within the healthcare system. Strategies aiming 
to improve vaccine confidence among BIPOC HCP need to 
acknowledge and address this mistrust of the medical system 
to be effective [41]. Approaches must include culturally appro-
priate messaging that acknowledges that their experiences as 
healthcare workers and healthcare consumers may differ from 
those of their white counterparts.
NUANCES OF ADDRESSING VACCINE CONFIDENCE 
AMONG IMMIGRANT AND REFUGEE COMMUNITIES
Immigration from countries and communities in every conti-
nent over many centuries has been the defining event under-
lying the creation of an increasingly diverse population in the 
United States. Attitudes towards vaccination may be not suffi-
ciently granular to account for the myriad of socioeconomic, 
cultural, religious, and other factors that could inform consid-
erations for addressing vaccine confidence and uptake in these 
disparate communities. In addition to the harmful effects of so-
cial determinants of health and systemic racism experienced by 
US-born BIPOC, immigrant and refugee populations experi-
ence the compounded impact of anti-immigration policies and 
rhetoric, language barriers, health illiteracy, and unfamiliarity 
with navigating the US healthcare system [50, 51]. It is common 
for immigrants and refugees to maintain social media contact 
with family and friends in their country of origin, compounding 
an infodemic (ie, overabundance of rapidly spreading informa-
tion, some accurate and some inaccurate, making it difficult to 
identify trustworthy information sources) of misinformation 
through which they must navigate. The dominant narrative 
around the COVID-19 vaccine in other countries frequently 
differs from that in the United States. Therefore, educational 
programs that target dominant messages in US social media 
may not influence vaccine confidence in these populations. It 
is imperative that US public health officials leverage existing 
immigrant and refugee community organizations to better 
understand the infodemics affecting immigrant and refugee 
populations. We must pursue tailored education campaigns 
based on in-depth analysis of norms, beliefs, misinformation, 
and preconceived notions prevalent in any given community 
that may be culturally or geographically distinct. The pandemic 
has fueled an intense increase in nationalism with calls ini-
tially to prioritize vaccines for residents and citizens ahead of 
undocumented immigrants. However, this position is contrary 
to the urgent public health need to vaccinate as many people 
as possible, particularly when immigrants, including undocu-
mented immigrants, comprise a large constituency of essential 
workers at highest risk for COVID-19 [52]. Therefore, although 
it is important to remove language barriers to vaccination ef-
forts, equally important are efforts to remove barriers related 
to immigration status, such as requiring proof of residency or 
citizenship, or insurance status, and explicitly communicate to 
these populations that they will not be turned away or reported 
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THE RIGHT COMMUNICATION STRATEGY
Well conceived and appropriately designed background re-
search on the addressable and actionable factors influencing 
vaccine confidence should initially be conducted. Differences 
in vaccine acceptance rates vary across demographics based on 
multiple factors, including age, ethnicity, socioeconomic status, 
geographic location, and source of information. Therefore, we 
must use multifaceted approaches to build vaccine confidence 
in ethnically diverse communities, focusing on both the de-
livered messages and the messengers.
A practical communication approach requires public health 
officials and HCP to earn the community’s trust through cul-
tural humility, transparency, and open-mindedness. First, a 
nonprescriptive, bidirectional listening and learning approach 
should be adopted, sharing respect for and empathy with cul-
tural beliefs and norms within these communities. When pos-
sible, partnerships with trusted community resources such as 
faith-based leaders, community organizers, and community 
mentors should be emphasized to have a multipronged ap-
proach. Second, we must recognize our knowledge gaps in 
the pandemic’s trajectory and the COVID-19 vaccine trial re-
sults. Third, we should empathize with our audience, respect 
their opinions, and understand the impact of social injustice, 
health inequities, and systemic racism in healthcare on people’s 
attitudes. A condescending or dismissive approach will be in-
effective, particularly in the context of conspiracy theories or 
misinformation that are often prevalent and significantly in-
fluence attitudes about vaccination. Public health officials and 
healthcare professionals should openly address past and on-
going injustices with empathy and reassurance based on scien-
tific evidence.
We may encounter individuals with varying levels of am-
bivalence influencing their likelihood of accepting vaccines 
after hearing our messages (Table 1). Sentiments toward 
COVID-19 vaccines may include “resistance” due to firmly 
held beliefs; “misinformation” by way of myths or inappro-
priate messages; a “wait and see” approach to gather more 
information before committing; or “acceptance” and will-
ingness to confirm and share experiences with others. It is 
important to note that these sentiments do not represent a 
linear progression. Individuals may experience bidirectional 
transition between these feelings depending on personal ex-
perience and societal input, and they should be given space 
(and grace) to change their minds. Table 1 illustrates our 
proposed strategic approach to a shared discussion about de-
liberation with individuals experiencing these 4 sentiments 
toward COVID-19 vaccines. Our messages should be flexible 
to probe our patients’ position, to accommodate dynamic 
groups of constituents, and to focus on specific concerns that 
shape their attitudes toward COVID-19 vaccine acceptance, 
with an overarching goal to helping to make informed deci-
sions about vaccine choices [54].
IMPORTANCE OF INCLUDING TRUSTED 
MESSENGERS IN THE ALLOCATION, DISTRIBUTION, 
AND COMMUNICATION STRATEGY
The importance of trusted messengers in the allocation and 
distribution strategy cannot be overstated. Trusted messengers 
in these communities may not include traditional healthcare 
professionals, due to the historical underpinnings with prior 
unethical experimentation in this population. Faith or com-
munity leaders and other influential persons may be viewed as 
trusted messengers in the BIPOC population. They should be 
an integral part of activities designed to engage, educate, and 
ultimately positively influence prospective vaccine recipients 
(Figure 1). More importantly, this collaboration should incor-
porate empathic listening and cocreation of solutions with the 
community leaders based on their needs, rather than bringing 
predetermined solutions without their involvement [55]. A uni-
versity hospital in California implemented a 3-tiered approach 
to engage the community in a vaccination strategy [56]. They 
began with the direct empowerment of local faith leaders 
through a COVID-19 faith summit, after which the pastors 
themselves coordinated information sessions about vaccines to 
their congregations. The faith leaders helped members make 
appointments and register using paper forms to avoid a tech-
nology barrier, and, finally, the mobile vaccine clinics them-
selves were held on church grounds [56]. Although the AI/AN 
community experience multiple underlying systemic inequities 
possibly creating barriers to vaccination, tribal autonomy with 
design and implementation of vaccine distribution efforts has 
contributed to higher vaccination rates among tribal citizens 
compared with other racial groups [36]. For example, in the 
Navajo Nation, traditional healers were instrumental in leading 
the way with COVID-19 vaccine messaging by choosing to 
be vaccinated first in the community, along with healthcare 
workers, President Jonathan Nez, and other community leaders. 
The transparent, coordinated strategy [57, 58] emphasized 
clear, unified messaging in both English and Navajo languages, 
and it included utilization of digital and social media channels, 
all of which influenced increased uptake of vaccines in this 
community.
Although many trusted messengers may come from outside 
of the healthcare workforce, vaccine confidence can certainly 
be influenced by having ethnically diverse healthcare workers 
with good rapport with their communities engage in frequent 
open and transparent dialogues to address people’s questions 
[41]. Concerns and ambivalence toward the vaccine should be 
addressed and welcomed in a nonjudgmental manner with a 
bidirectional discussion opportunity. The BIPOC healthcare 
professionals lead many of the outreach programs or personal 
engagement mentioned in this article [45–48, 53, 56]; health-
care organizations should leverage this work that is already 
being done by partnering with BIPOC healthcare professionals 
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messages and increase their reach into BIPOC communities. 
However, although BIPOC healthcare professionals need more 
significant elevation in these efforts, the burden does not fall 
solely on their shoulders, mainly because there are so few of 
them. Hospitals and professional medical societies should de-
velop public-facing resources that acknowledge concerns and 
answer questions pertinent to BIPOC communities (Figure 1). 
These resources should be easily accessible, use language that 
is easy to understand, and be available in multiple formats for 
different learning styles.
Although it is important to engage faith, community leaders, 
and BIPOC healthcare professionals as trusted messengers in 
vaccine uptake strategies, we acknowledge that an approach that 
engages only these leaders is not feasible. Receiving COVID-19 
vaccine information from healthcare professionals with whom 
individuals already have an established patient care relationship 
may have utility in increasing vaccine trust among BIPOC indi-
viduals [59]; therefore, more efforts to place vaccines in primary 
care offices is important. Similarly, another important trusted 
source may be community health centers. These locations are 
uniquely positioned within the communities to ensure commu-
nication with people who may have questions or concerns about 
vaccines. Community health centers provide primary care serv-
ices to many individuals experiencing homelessness or living 
in low-income housing and rural neighborhoods, including 
many BIPOC. An analysis of community health center COVID-
19 vaccinations across the country reported that over 50% of 
people receiving both doses of their vaccines were BIPOC, with 
vaccination rates exceeding the national rates [60].
VACCINE ACCESS
Notwithstanding the justifiable deliberations that BIPOC com-
munities may experience regarding COVID-19 acceptance, 
the discussion about inequitable vaccine uptake must include 
1 additional important component: access to vaccines. The 
Advisory Committee on Immunization Practices suggested a 
phased vaccine rollout plan because it was apparent that the 
demand for COVID-19 vaccines would exceed supply during 
the first months of the national COVID-19 vaccination pro-
gram, preventing everyone from being able to get vaccinated 
at the same time [61]. This approach is helpful; however, al-
though the Federal recommendations for prioritizing of in-
dividuals for vaccination accounted for mitigation of risk for 
older adults and those with specific comorbidities, decisions on 
how prioritization occurred in practice were left to the states. 
The National Academy of Sciences suggests that any framework 
for equitable distribution should “explicitly address the higher 
burden of COVID-19 experienced by the populations affected 
most heavily, given their exposure and compounding health in-
equities”, and it recommended that across all priority groups, 
Table 1. Four Sentiments Toward Coronavirus Disease 2019 (COVID-19) Vaccines and Approach to Shared Discussion and Deliberation




Resistance Firmly held beliefs Speed of vaccine production 
and approval  
Previous vaccine adverse 
experiences  
Vaccine not seen as a high 
priority  
Feeling marginalized  
Doubts legitimacy of COVID-
19 pandemic
Low Clarify prior scientific work on vaccine technology, 
with pooled scientific and financial resources 
leading to successful vaccine development  
Reassure that data and safety monitoring proced-
ures were followed in all stages of development 
and approval  
Ensure participation of community representatives 
in the Emergency Use Authorization process  
Advocate for long-term public health and socioec-
onomic plan  
Use culturally competent tools for outreach  




Influenced by widespread 
myths, misconceptions, and 
falsehoods
Trust the wrong messengers 
Reliance on the internet and 
social media for health-
related information  
Political bias
Low-medium Identify and educate trusted messengers  
Clarify scientific data and send consistent mes-
sages  
Use the internet and social media to spread accu-
rate information  
Stick to the facts: avoid partisan arguments or as-
sociating vaccination with specific politicians
Wait and see 
approach
Want to watch vaccine recipi-
ents’ experiences  
Searching for more scientific 
data and trusted messengers 
Gathering more information 
before committing
Unsure about vaccine safety 
and efficacy  
Insufficient mid- and long- 
term data  
Personal health issues
Medium-high Respect individual choices  
Acquiesce vaccine questions  
Highlight limitations of current scientific knowledge 
Underline scientific consensus  
Express willingness to update information and 
accept changes
Acceptance Feel comfortable with informa-
tion about the vaccine and 
ready to receive it
May have moved through 
any or all of the previous 3 
sentiments
High Encourage willingness to confirm and share their 
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there should be an accounting for prioritization of those with 
higher structural vulnerability [33]. An evaluation of these 
state-directed practices demonstrated that in many cases, the 
states deprioritized certain groups such as essential workers, 
who are predominantly BIPOC individuals, and often ignored 
other groups such as American Indian/Alaska Native popula-
tions or those living in low-income housing [62]. Furthermore, 
the reliance of vaccine appointments on electronic scheduling 
creates another hindrance to people without reliable access 
to technology [63]. The development of this information in 
English only serves as a barrier to individuals whose primary 
communication language is different [64].
The positive impact of intentional, directed vaccine ac-
cess is apparent in the story of the Navajo Nation, despite the 
American Indian/Alaska Native community experiencing some 
of the worst morbidity and mortality from COVID-19 [5]. As of 
April 5, 2021, IHS had received more than 1.5 million COVID-
19 vaccine doses, translating to approximately 75 000 doses per 
100 000 people served, one of the highest rates of vaccine de-
livery nationwide compared with state vaccination programs 
[36]. A  coordinated effort among the IHS, Navajo Nation, 
and tribal health organizations organized a streamlined vac-
cine rollout with lowered age administration priority groups, 
centralized vaccine delivery, and mass walk-in vaccination 
efforts that resulted in almost 50% of the Navajo population 
receiving their first vaccine dose [57, 58]. However, the expe-
rience in the tribal community may not reflect that of the 78% 
of the American Indian/Alaska Native community who reside 
in urban populations outside of tribal lands [65], and similarly 
BIPOC outside of a system such as this with a focused effort to-
ward vaccination may experience many barriers to vaccination, 
including language, distance, and lack of culturally appropriate 
information. In these situations, the approach to equitable up-
take in these populations should remove these barriers by em-
phasizing language and culturally congruent messaging, with 
flexible and convenient vaccination opportunities such as 
pop-up clinics or home vaccinations (Figure 1).
CONCLUSIONS
Coronavirus disease 2019 has unveiled for the world something 
that BIPOC living in America have endured for centuries; that 
they are at the highest risk of inequitable care and subsequent 
devastating health disparities. Because we consider vaccines as 
a vehicle for ending this pandemic, our only successful move 
forward ensures that the communities most impacted are pro-
tected. Vaccine confidence can be strengthened if we begin with 
respect and transparency and if our approaches to vaccine al-
location, distribution, and messaging start and end with an eq-
uitable lens. Therefore, the approach to COVID-19 vaccines in 
BIPOC must focus on equity instead of hesitancy.
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